logo-loader

New Confidence in Chinese Banks as Bank of America Ups Stake

china350_493668537949e.jpg

News that Bank of America upped its stake in China Construction Bank (601939, SH; 0939,HK) by 9 percent to 19.13 percent brought the CSI 300 Index up by 6.29 percent as confidence was raised in Chinese banks.

China Construction Bank advanced 5.2 percent in Shanghai and 3.41 in Hong Kong. Shanghai Pudong Development bank was up 6.88 in Sanghai. Industrial and Commercial bank went up by 2.93 percent in Shanghai and 2.89 in Hong Kong.
 
Bank of America first invested in China Construction Bank in June 2005, buying a US$3 billion stake before the bank had gone public. It invested another $1.87 billion this May, bringing its stake to 10.8 percent. By exercising its call option, the U.S. bank was able to buy Hong Kong shares in CCB at a 40 percent discount to their closing price on the 28th of November.
 
Central Huijin Investment Co., a unit of China's $200 billion sovereign wealth fund, has a controlling 57.06 percent stake in CCB. It has said previously that it plans to increase its stakes will buy shares in Industrial & Commercial Bank of China Ltd., Bank of China Ltd. and China Construction Bank.
 
Mainland markets hoped to recover as national pension funds invest 10 billion 

The South China Morning Post reported today that the National Social Security Fund, - China's national pension fund - spent 10 billion yuan ($1.5 billion) buying mainland-listed shares last month in order to support the country's stock market.  
 
The government has been encouraging the Central Huijin and Chinese pension funds to invest more in the country's stock markets
 
According to local lore, the last time the National Social Security Fund splashed out on stocks, in October 2006, the CSI index soared from 1,800 to 6,000 within a year.
 
Coal, steel and iron all up

In the mainland markets, coal stocks gained momentum in the afternoon session of the trading and soared 9 percent on average. Over a dozen closed at their upper price limit. Steel and iron rose by 5 percent.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Emerald Bioscience gearing up for first in-human clinical trial in Australia...

Emerald Bioscience Inc (OTCMKTS:EMBI) CEO Brian Murphy spoke with Proactive’s Steve Darling at the 12th annual LD Micro Conference in Bel Air, California, about the medical cannabis company’s proprietary suite of technologies, including its lead product candidate that could reduce intraocular...

12 minutes ago

2 min read